Mednax reports Q3 GAAP EPS $0.37 from continuing ops, revenue $493M, adjusted EPS $0.46

Pediatrix Medical Group, Inc.

2021-Q3 EPS reported $0.97 revenue$1,412,661,000

Net revenue $492.9M, up 7% YoY; same-unit revenue +5.9%, driven by 6.5% volume increase.
GAAP EPS $0.37 vs loss $0.03 prior year; Adjusted EPS $0.46 vs $0.37.
Adjusted EBITDA $73.4M vs $72.8M; no CARES Act funds in Q3 2021 vs $14.2M in Q3 2020.
Used $20M to invest in Brave Care; redeemed $750M 5.25% notes in Jan; cut revolver to $600M from $1.2B.
Cash at Sep 30: $358M; net debt $642M; no debt on revolver.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.